| Product NDC: | 49884-258 |
| Proprietary Name: | Metaproterenol Sulfate |
| Non Proprietary Name: | Metaproterenol Sulfate |
| Active Ingredient(s): | 10 mg/1 & nbsp; Metaproterenol Sulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-258 |
| Labeler Name: | Par Pharmaceutical Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA072024 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19880628 |
| Package NDC: | 49884-258-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (49884-258-01) |
| NDC Code | 49884-258-01 |
| Proprietary Name | Metaproterenol Sulfate |
| Package Description | 100 TABLET in 1 BOTTLE (49884-258-01) |
| Product NDC | 49884-258 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metaproterenol Sulfate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19880628 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical Inc |
| Substance Name | METAPROTERENOL SULFATE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |